Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 5, 1999, Pages 1291-1298

  Leitinger, Norbert ^a,d   Watson, Andrew D ^a   Hama, Susan Y ^a   Ivandic, Boris ^a   Qiao, Jian Hua ^a   Huber, Joakim ^a   Faull, Kym F ^a   Grass, David S ^b   Navab, Mohamad ^a   Fogelman, Alan M ^a   De Beer, Frederick C ^c   Lusis, Aldons J ^a   Berliner, Judith A ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Chrysalis DNX Transgenic Sciences   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF VIENNA   (Austria)

^e Depts of Pathology and Medicine   (United States)

Author keywords

Inflammation; LDL oxidation; Lipid peroxidation; Mice; Phospholipids; Spectrum analysis, mass; Transgenic

Indexed keywords

ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2; PHOSPHOLIPID; PHOSPHORYLCHOLINE; POLYUNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LIPID OXIDATION; MONOCYTE; MOUSE; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032914865     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.5.1291     Document Type: Article

References (44)

1. 2. Arterioscler Thromb Vasc Biol. 1999;19: 1284-1290.
2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
3. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
4. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM. The yin and yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscl Thromb Vasc Biol. 1996;16:831-842.
5. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994; 344:793-795.
6. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995;91:2488-2496.
7. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20:707-727.
8. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85: 1260-1266.
9. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M. Protective effect of high density lipoprotein associated paraoxonase. J Clin Invest. 1995;96:2882-2891.
10. Watson, AD, Leitinger N, Navab M, Faull KF, Hörrkö S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G. Fogelman AM, Berliner JA. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997;272:13597-13607.
11. Hörkkö S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W, Witztum JL. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids: recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest. 1996;98: 815-825.
12. Liao F, Andalibi A, Qiao JH, Allayee H, Fogelman AM, Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest. 1994;94:877-884.
13. Berliner JA, Leitinger N, Watson AD, Huber J, Fogelman AM, Navab M. Oxidized lipids in atherogenesis: formation, destruction and action. Thromb Haemost. 1997;78:195-199.
14. Cirino G, Cicala C, Sorrentino L, Maiello FM, Browning JL. Recombinant secreted phospholipase A2 induces a cynovitis-like inflammation in the rat air pouch. J Rheumatol. 1994;21:824-829.
15. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J Clin Invest. 1996;97:2233-2241.
16. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins of human serum. J Clin Invest. 1955;43:1345-1353.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
18. 2 mimics cell-mediated oxidative modification. J Lipid Res. 1988;29: 745-753.
19. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest. 1993;92:471-478.
20. Warden CH, Qiao JH, Castellani LW, Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 1993;261: 469-472.
21. Navab M, Hough GP, Stevenson LW, Drinkwater DC, Kaks H, Fogelman AM. Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J Clin Invest. 1988;82:1853-1863.
22. Fogelman AM, Sykes K, Van Lenten BJ, Territo MC, Berliner JA. Modification of the Recalde method for the isolation of human monocytes. J Lipid Res. 1988;29:1243-1247.
23. Auerbach BJ, Kiely JS, Cornicelli JA. A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Anal Biochem. 1992;20:375-380.
24. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
25. Kaluzny MA, Duncan LA, Merritt MV, Epps DE. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res. 1985;26:135-140.
26. Han X, Gubitosi-Klug RA, Collins BJ, Gross RW. Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. Biochemistry. 1996;35:5822-5832.
27. Han X, Gross RW. Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc Natl Acad Sci USA. 1994;91:10635-10639.
28. Parthasarathy S, Wieland E, Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low-density lipoproteins. Proc Natl Acad Sci USA. 1989;86:1046-1050.
29. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H, Fogelman AM. Monocyte transmigration induced by modification of low density lipoprotein in co-cultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991;88:2039-2046.
30. 2 in human atherosclerotic plaques. Atherosclerosis. 1995;118:173-181.
31. 2 in normal and atherosclerotic arteries. Arterioscler Thromb Vasc Biol. 1997;17:300-309.
32. Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA. 1995;92:821-825.
33. Ameli S, Hultgardh-Nilsson A, Regnstrom J, Calara F, Yano J, Cercek B, Shah PK, Nilsson J. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscl Thromb Vasc Biol. 1996;16:1074-1079.
34. Palinski W, Hörkkö S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest. 1996;98:800-814.
35. Sugimoto H, Hayashi H, Yamashita S. Purification, cDNA cloning and regulation of lysophospholipase from rat liver. J Biol Chem. 1996;271: 7705-7711.
36. 2: influence on lipoprotein metabolism. J Lipid Res. 1997;38: 2232-2239.
37. Yamamoto S, Suzuki H, Ueda N. Arachidonate 12-lipoxygenase. Prog Lipid Res. 1997;36:23-41.
38. Kleinfeld AM, Chu P, Romero C. Transport of long-chain native fatty acids across lipid bilayer membranes indicates that transbilayer flip-flop is rate limiting. Biochemistry. 1997;36:14146-14158.
39. Elsing C, Kassner A, Stremmel W. Effect of surface and intracellular pH on hepatocellular fatty acid uptake. Am J Physiol. 1996;271:1067-1073.
40. Sevanian A, Wratten ML, McLeod LL, Kim E. Lipid peroxidation and phospholipase A2 activity in liposomes composed of unsaturated phospholipids: a structural basis for enzyme activation. Biochim Biophys Acta. 1988;961:316-327.
41. Sevanian A, Kim E. Phospholipase A, dependent release of fatty acids from peroxidized membranes. Free Radic Biol Med. 1985;1:263-271.
42. 2 toward peroxidized phosphatidylcholine vesicles. Arch Biochem Biophys. 1993;304:123-132.
43. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 1995;80:919-927.
44. Bamberger M, Lund-Katz S, Phillipis M, Rothblat G. Mechanism of the hepatic lipase induced accumulation of HDL cholesterol by cells in culture. Biochemistry. 1985;24:3693-3701